Istari Oncology
Mr. Bonczek has been instrumental in helping companies through IPOs, secondary equity offerings, private placements, transactional advice for M&As, strategic planning, and collaboration agreements. He is also President and Chief Financial Officer of MedBlue Incubator, Inc., and has served as President, Director, CFO, and General Counsel of b3 bio, Inc.; Chief Financial Officer, General Counsel, and Chief Administrative Officer of Trimeris, Inc.; and Chief Counsel and Global Director of Safety, Health and Environment of Dupont. He is a founding partner, Director, and President of Aspen Tree Capital. He serves on the boards and advisory boards of several other life science-related companies. Mr. Bonczek received an AB in chemistry and a JD degree from the University of North Carolina. He also holds an MBA from the Wharton School at the University of Pennsylvania.
This person is not in the org chart
This person is not in any offices
Istari Oncology
Istari Oncology, Inc. is a clinical-stage biotechnology company focused on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors.